Business Description
Shanghai Labway Clinical Laboratory Co Ltd
ISIN : CNE100004RG8
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.18 | |||||
Equity-to-Asset | 0.65 | |||||
Debt-to-Equity | 0.18 | |||||
Debt-to-EBITDA | -1.51 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.42 | |||||
Beneish M-Score | -1.56 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6 | |||||
3-Year FCF Growth Rate | 1.9 | |||||
3-Year Book Growth Rate | 8.6 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 12.39 | |||||
9-Day RSI | 25.51 | |||||
14-Day RSI | 34.8 | |||||
6-1 Month Momentum % | 42.98 | |||||
12-1 Month Momentum % | -11.46 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.45 | |||||
Quick Ratio | 2.93 | |||||
Cash Ratio | 1.17 | |||||
Days Inventory | 88.31 | |||||
Days Sales Outstanding | 226.37 | |||||
Days Payable | 111.24 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.4 | |||||
Shareholder Yield % | -2.17 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 18.23 | |||||
Operating Margin % | -1.58 | |||||
Net Margin % | -10.51 | |||||
FCF Margin % | 9.53 | |||||
ROE % | -10.07 | |||||
ROA % | -6.27 | |||||
ROIC % | -1.56 | |||||
ROC (Joel Greenblatt) % | -14.4 | |||||
ROCE % | -9.59 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.18 | |||||
PB Ratio | 2.19 | |||||
Price-to-Tangible-Book | 2.23 | |||||
Price-to-Free-Cash-Flow | 23.2 | |||||
Price-to-Operating-Cash-Flow | 14.48 | |||||
EV-to-EBIT | -16.86 | |||||
EV-to-EBITDA | -16.86 | |||||
EV-to-Revenue | 2.04 | |||||
EV-to-FCF | 21.38 | |||||
Price-to-Net-Current-Asset-Value | 3.54 | |||||
Earnings Yield (Greenblatt) % | -5.93 | |||||
FCF Yield % | 4.33 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Shanghai Labway Clinical Laboratory Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 1,724.522 | ||
EPS (TTM) (Â¥) | -0.454 | ||
Beta | 1 | ||
Volatility % | 51.53 | ||
14-Day RSI | 34.8 | ||
14-Day ATR (Â¥) | 0.473415 | ||
20-Day SMA (Â¥) | 10.647 | ||
12-1 Month Momentum % | -11.46 | ||
52-Week Range (Â¥) | 7.34 - 14.77 | ||
Shares Outstanding (Mil) | 400.52 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Shanghai Labway Clinical Laboratory Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Shanghai Labway Clinical Laboratory Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Shanghai Labway Clinical Laboratory Co Ltd Frequently Asked Questions
What is Shanghai Labway Clinical Laboratory Co Ltd(SZSE:301060)'s stock price today?
When is next earnings date of Shanghai Labway Clinical Laboratory Co Ltd(SZSE:301060)?
Does Shanghai Labway Clinical Laboratory Co Ltd(SZSE:301060) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |